Biologics of Allergy

The advent of molecular techniques has resulted in the ability to tailor medications to specific protein targets. Such therapies are known as biologic immunomodulators, or more commonly, biologics. Since their introduction, these therapies have been designed to specifically target the molecular pathways involved in the pathogenesis of various autoimmune and inflammatory disorders.

The advent of molecular techniques has resulted in the ability to tailor medications to specific protein targets. Such therapies are known as biologic immunomodulators, or more commonly, biologics. 

  • Receptor Blocking Agents
  • Cytokine Blocking Antibodies
  • Fusion Receptors
  • Anti-Immunoglobulin E
  • The Future of Biologics: Applications for Food Allergy

Related Conference of Biologics of Allergy

November 2-3, 2017

9th World Congress and Expo on Immunology

Atlanta, Georgia, USA
November 02-03, 2017

9th World Congress on Immunity, Inflammation and Immunotherapies

Atlanta, Georgia, USA
November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress & B2B

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE
April 19-20, 2018

7th World Congress on Immunology

Amsterdam, Netherlands
May 28-29, 2018

World Congress on Allergy and Immunotherapy

Osaka, Japan

9th European Immunology Conference

June 14-16, 2018 Rome, Italy
July 05-07, 2018

EuroSciCon Conference on Immunology Conference 2018

Vienna, Austria
July 12-13, 2018

5th International Conference on Parasitology

Paris, France

Biologics of Allergy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in